
C. 'Harris' Floudas
@chfloudas
Active on: @[email protected] and @floudas.bsky.social
ID: 24247824
https://www.linkedin.com/in/floudas 13-03-2009 20:34:08
9,9K Tweet
772 Followers
996 Following



Aristotle was the first to notice honeybees dancing. In 1927 Karl von Frisch decoded the waggle. How it works was "explained" by MV Srinivasan AM FRS in the 1990s. Except Laura Luebbert, PhD found his papers are junk. A 🧵 about her discovery & our report: arxiv.org/abs/2405.12998 1/




A real-world validation of the value of #wearables in assessing treatment effect in #Oncology by Vivek Venkataramani at Universitätsklinikum Würzburg nature.com/articles/s4169…

🔥 Excited to present iterative MedRAG (i-MedRAG) that pushes the performance of GPT-3.5 to ~70.0% on MedQA. Great work led by Guangzhi Xiong!

An analysis of demographics of participants in clinical trials at the NCI Clinical Center from 2005-2020 compared with the U.S. population and other trial mechanisms finds disparities in clinical trials. Read now: oxford.ly/3LPWIwP Fatima Karzai, M.D.




Checkpoint inhibitors are increasingly common and often highly effective cancer therapies But they can cause hepatitis This systematic review shows: 1 in 6 are steroid refractory 1 in 5 recurs with rechallenge Wei Zhang MD PHD Hepatology Communications journals.lww.com/hepcomm/fullte…



A great presentation of important work to increase equitable representation in clinical trials by whenwetrial.org Touch, The Black Breast Cancer Alliance ™️ at #AACRdisp24.

Our own Dr Cecilia Monge B, MD NCI CCR Med Onc Service showcasing her work on CRC genomic research inclusion #AACRdisp24



🔥 Excited to share our TrialGPT work published in Nature Communications today. 🧪 Patient recruitment is challenging for clinical trials. 🤖 We introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models. nature.com/articles/s4146…

Had a terrific time collaborating with Wei Zheng, Sisi Sarkizova (Moderna) and Michele Ceccarelli (Sylvester Comprehensive Cancer Center) for a review on mRNA-based neoantigen-directed cancer immunotherapy, now available from Journal for ImmunoTherapy of Cancer jitc.bmj.com/content/13/1/e…

I am deeply grateful to my co-authors from Center for Cancer Research, National Cancer Institute, NIH (Bethesda 🇺🇸) @gulleyj1 Andrea Apolo, M.D. Fatima Karzai, M.D. Elias Chandran, MBBS @elisabetta Elisabetta Xue